{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:31:40Z","timestamp":1787585500394,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04352-6","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:52:35Z","timestamp":1762876355000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Role of procalcitonin in identifying systemic inflammatory response syndrome and sepsis in acute-on-chronic liver failure and its impact on survival"],"prefix":"10.1186","volume":"25","author":[{"given":"Suriya","family":"Nedunchezhian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athish","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0707-3459","authenticated-orcid":false,"given":"Ganesh","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiran","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Musunuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Ganesh","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddheesh","family":"Rajpurohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"4352_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","volume":"3","author":"SK Sarin","year":"2009","unstructured":"Sarin SK, Kumar A, Kumar A, Almeida JA, Chawla YK, Fan ST, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL). Hepatol Int. 2009;3:269\u201382.","journal-title":"Hepatol Int"},{"key":"4352_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrgastro.2015.219","volume":"13","author":"SK Sarin","year":"2016","unstructured":"Sarin SK, Choudhury A. Acute-on-chronic liver failure: terminology, mechanisms and management. Nat Rev Gastroenterol Hepatol. 2016;13:131\u201349.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4352_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.41","volume":"2","author":"V Arroyo","year":"2016","unstructured":"Arroyo V, Moreau R, Kamath PS, Jalan R, Gin\u00e8s P, Nevens F, et al. Acute-on-chronic liver failure in cirrhosis. Nat Rev Dis Primers. 2016;2:16041.","journal-title":"Nat Rev Dis Primers"},{"key":"4352_CR4","doi-asserted-by":"crossref","unstructured":"Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. Chest. 1992;101:1644\u201355.","DOI":"10.1378\/chest.101.6.1644"},{"key":"4352_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002031","volume":"94","author":"Y Shi","year":"2015","unstructured":"Shi Y, Yan H, Zhou Z, Fang H, Li J, Ye H, et al. The clinical course of cirrhosis patients hospitalized for acute hepatic deterioration: a prospective bicentric study. Medicine. 2015;94:e2031.","journal-title":"Medicine"},{"key":"4352_CR6","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1007\/s00134-009-1472-x","volume":"35","author":"CJ Karvellas","year":"2009","unstructured":"Karvellas CJ, Pink F, McPhail M, Cross T, Auzinger G, Bernal W, et al. Predictors of bacteraemia and mortality in patients with acute liver failure. Intensive Care Med. 2009;35:1390\u20136.","journal-title":"Intensive Care Med"},{"key":"4352_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/hep.27849","volume":"62","author":"T Gustot","year":"2015","unstructured":"Gustot T, Fernandez J, Garcia E, Morando F, Caraceni P, Alessandria C, et al. Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. Hepatology. 2015;62:243\u201352.","journal-title":"Hepatology"},{"key":"4352_CR8","first-page":"396","volume":"86","author":"B M\u00fcller","year":"2001","unstructured":"M\u00fcller B, White JC, Nyl\u00e9n ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 2001;86:396\u2013404.","journal-title":"J Clin Endocrinol Metab"},{"key":"4352_CR9","volume":"2011","author":"IA Meynaar","year":"2011","unstructured":"Meynaar IA, Droog W, Batstra M, Vreede R, Herbrink P. In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il-6, or LBP. Crit Care Res Pract. 2011;2011:594645.","journal-title":"Crit Care Res Pract"},{"key":"4352_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","volume":"375","author":"L Bouadma","year":"2010","unstructured":"Bouadma L, Luyt C-E, Tubach F, Cracco C, Alvarez A, Schwebel C, et al. Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010;375:463\u201374.","journal-title":"Lancet"},{"key":"4352_CR11","doi-asserted-by":"publisher","first-page":"723","DOI":"10.5604\/17322693.1158796","volume":"69","author":"V Dymicka-Piekarska","year":"2015","unstructured":"Dymicka-Piekarska V, Wasiluk A. [Procalcitonin (PCT), contemporary indicator of infection and inflammation]. Postepy Hig Med Dosw. 2015;69:723\u20138.","journal-title":"Postepy Hig Med Dosw"},{"issue":"Suppl 1","key":"4352_CR12","first-page":"S57","volume":"49","author":"P Maruna","year":"2000","unstructured":"Maruna P, Nedeln\u00edkov\u00e1 K, G\u00fcrlich R. Physiology and genetics of procalcitonin. Physiol Res. 2000;49(Suppl 1):S57\u201361.","journal-title":"Physiol Res"},{"key":"4352_CR13","volume-title":"Systemic inflammatory response syndrome","author":"RK Chakraborty","year":"2025","unstructured":"Chakraborty RK, Burns B. In: StatPearls, editor. Systemic inflammatory response syndrome. Treasure Island (FL): StatPearls Publishing; 2025."},{"key":"4352_CR14","doi-asserted-by":"publisher","first-page":"943","DOI":"10.21037\/jtd.2017.03.125","volume":"9","author":"PE Marik","year":"2017","unstructured":"Marik PE, Taeb AM, SIRS. qSOFA and new sepsis definition. J Thorac Dis. 2017;9:943\u20135.","journal-title":"J Thorac Dis"},{"key":"4352_CR15","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"4352_CR16","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","volume":"144","author":"R Moreau","year":"2013","unstructured":"Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on-Chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1426\u2013e14379.","journal-title":"Gastroenterology"},{"key":"4352_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jhep.2018.12.008","volume":"70","author":"T Gustot","year":"2019","unstructured":"Gustot T, Jalan R. Acute-on-chronic liver failure in patients with alcohol-related liver disease. J Hepatol. 2019;70:319\u201327.","journal-title":"J Hepatol"},{"key":"4352_CR18","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1111\/jgh.13340","volume":"31","author":"SV Shalimar","year":"2016","unstructured":"Shalimar SV, Singh SP, Duseja A, Shukla A, Eapen CE, et al. Acute-on-chronic liver failure in india: the Indian National association for study of the liver consortium experience. J Gastroenterol Hepatol. 2016;31:1742\u20139.","journal-title":"J Gastroenterol Hepatol"},{"key":"4352_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101016","volume":"6","author":"S Johansen","year":"2024","unstructured":"Johansen S, Langkj\u00e6r S, Rasmussen DN, Israelsen M, Torp N, Lindvig K, et al. Infections increase the risk of decompensation and death in patients with early alcohol-related liver disease. JHEP Rep. 2024;6:101016.","journal-title":"JHEP Rep"},{"key":"4352_CR20","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1002\/hep.31984","volume":"74","author":"L Otero Sanchez","year":"2021","unstructured":"Otero Sanchez L, Karakike E, Njimi H, Putignano A, Degr\u00e9 D, Hites M, et al. Clinical course and risk factors for infection in severe forms of alcohol-associated liver disease. Hepatology. 2021;74:2714.","journal-title":"Hepatology"},{"key":"4352_CR21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","volume":"12","author":"G Szabo","year":"2015","unstructured":"Szabo G, Petrasek J. Inflammasome activation and function in liver disease. Nat Rev Gastroenterol Hepatol. 2015;12:387\u2013400.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4352_CR22","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jhep.2017.06.013","volume":"67","author":"T Gustot","year":"2017","unstructured":"Gustot T, Fernandez J, Szabo G, Albillos A, Louvet A, Jalan R, et al. Sepsis in alcohol-related liver disease. J Hepatol. 2017;67:1031\u201350.","journal-title":"J Hepatol"},{"key":"4352_CR23","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","volume":"137","author":"A Louvet","year":"2009","unstructured":"Louvet A, Wartel F, Castel H, Dharancy S, Hollebecque A, Canva-Delcambre V, et al. Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor. Gastroenterology. 2009;137:541\u20138.","journal-title":"Gastroenterology"},{"key":"4352_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5581587","volume":"2021","author":"A Borgonovo","year":"2021","unstructured":"Borgonovo A, Baldin C, Maggi DC, Victor L, Bansho ETO, Piedade J, et al. Systemic inflammatory response syndrome in patients hospitalized for acute decompensation of cirrhosis. Can J Gastroenterol Hepatol. 2021;2021:5581587.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"4352_CR25","first-page":"168","volume":"4","author":"R Behroozian","year":"2012","unstructured":"Behroozian R, Bayazidchi M, Rasooli J. Systemic inflammatory response syndrome and MELD score in hospital outcome of patients with liver cirrhosis. Middle East J Dig Dis. 2012;4:168.","journal-title":"Middle East J Dig Dis"},{"key":"4352_CR26","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.jhep.2017.07.008","volume":"67","author":"S Piano","year":"2017","unstructured":"Piano S, Tonon M, Vettore E, Stanco M, Pilutti C, Romano A, et al. Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis. J Hepatol. 2017;67:1177\u201384.","journal-title":"J Hepatol"},{"key":"4352_CR27","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1001\/jama.2016.20328","volume":"317","author":"E Raith","year":"2017","unstructured":"Raith E, Udy A, Bailey M, McGloughlin S, MacIsaac C, Bellomo R, et al. Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA. 2017;317:290\u2013300.","journal-title":"JAMA"},{"key":"4352_CR28","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1111\/jgh.13799","volume":"32","author":"A Choudhury","year":"2017","unstructured":"Choudhury A, Kumar M, Sharma BC, Maiwall R, Pamecha V, Moreau R, et al. Systemic inflammatory response syndrome in acute-on-chronic liver failure: relevance of golden window: a prospective study. J Gastroenterol Hepatol. 2017;32:1989\u201397.","journal-title":"J Gastroenterol Hepatol"},{"key":"4352_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s40121-020-00362-x","volume":"10","author":"J Chen","year":"2021","unstructured":"Chen J, Huang Z-B, Li H, Zheng X, Chen J-J, Wang X-B, et al. Early diagnostic biomarkers of sepsis for patients with acute-on-chronic liver failure: a multicenter study. Infect Dis Ther. 2021;10:281\u201390.","journal-title":"Infect Dis Ther"},{"key":"4352_CR30","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4103\/0019-5049.82676","volume":"55","author":"M Sinha","year":"2011","unstructured":"Sinha M, Desai S, Mantri S, Kulkarni A. Procalcitonin as an adjunctive biomarker in sepsis. Indian J Anaesth. 2011;55:266\u201370.","journal-title":"Indian J Anaesth"},{"issue":"2","key":"4352_CR31","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1590\/S1677-5538.IBJU.2014.0465","volume":"42","author":"YH Ko","year":"2016","unstructured":"Ko YH, Ji YS, Park S-Y, Kim SJ, Song PH. Procalcitonin determined at emergency department as an early indicator of progression to septic shock in patient with sepsis associated with ureteral calculi. Int Braz J Urol. 2016;42(2):270\u20136.","journal-title":"Int Braz J Urol"},{"key":"4352_CR32","doi-asserted-by":"publisher","first-page":"R234","DOI":"10.1186\/cc2877","volume":"8","author":"GP Castelli","year":"2004","unstructured":"Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and c-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care. 2004;8:R234-242.","journal-title":"Crit Care"},{"key":"4352_CR33","doi-asserted-by":"crossref","unstructured":"Wejnaruemarn S, Susantitaphong P, Komolmit P, Treeprasertsuk S, Thanapirom K. Procalcitonin and presepsin for detecting bacterial infection and spontaneous bacterial peritonitis in cirrhosis: A systematic review and meta-analysis. World J Gastroenterol. 2025;31.","DOI":"10.3748\/wjg.v31.i6.99506"},{"key":"4352_CR34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1086\/421997","volume":"39","author":"L Simon","year":"2004","unstructured":"Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39:206\u201317.","journal-title":"Clin Infect Dis"},{"key":"4352_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1476-5381.2009.00433.x","volume":"159","author":"KL Becker","year":"2010","unstructured":"Becker KL, Snider R, Nylen ES. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol. 2010;159:253\u201364.","journal-title":"Br J Pharmacol"},{"key":"4352_CR36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/cc306","volume":"3","author":"M Meisner","year":"1999","unstructured":"Meisner M, Tschaikowsky K, Palmaers T, Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care. 1999;3:45\u201350.","journal-title":"Crit Care"},{"key":"4352_CR37","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1097\/01.CCM.0000063440.19188.ED","volume":"31","author":"A Luzzani","year":"2003","unstructured":"Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med. 2003;31:1737\u201341.","journal-title":"Crit Care Med"},{"issue":"3","key":"4352_CR38","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/2229-5151.141356","volume":"4","author":"W Nargis","year":"2014","unstructured":"Nargis W, Ibrahim M, Ahamed BU. Procalcitonin versus C-reactive protein: usefulness as biomarker of sepsis in ICU patient. Int J Crit Illn Inj Sci. 2014;4:195.","journal-title":"Int J Crit Illn Inj Sci"},{"key":"4352_CR39","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1210\/jc.2002-021444","volume":"89","author":"KL Becker","year":"2004","unstructured":"Becker KL, Nyl\u00e9n ES, White JC, M\u00fcller B, Snider RH Jr. Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab. 2004;89:1512\u201325.","journal-title":"J Clin Endocrinol Metab"},{"key":"4352_CR40","doi-asserted-by":"publisher","DOI":"10.1177\/11772719241298197","volume":"19","author":"GT Kiya","year":"2024","unstructured":"Kiya GT, Asefa ET, Abebe G, Mekonnen Z. Procalcitonin guided antibiotic stewardship. Biomark Insights. 2024;19:11772719241298197.","journal-title":"Biomark Insights"},{"key":"4352_CR41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40560-017-0246-8","volume":"5","author":"AL Vijayan","year":"2017","unstructured":"Vijayan AL, Vanimaya null, Ravindran S, Saikant R, Lakshmi S, Kartik R, et al. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care. 2017;5:51.","journal-title":"J Intensive Care"},{"key":"4352_CR42","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/cid\/cis464","volume":"55","author":"P Schuetz","year":"2012","unstructured":"Schuetz P, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis. Clin Infect Dis. 2012;55:651\u201362.","journal-title":"Clin Infect Dis"},{"key":"4352_CR43","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","volume":"16","author":"E de Jong","year":"2016","unstructured":"de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016;16:819\u201327.","journal-title":"Lancet Infect Dis"},{"key":"4352_CR44","doi-asserted-by":"crossref","unstructured":"Jeon K, Suh JK, Jang EJ, Cho S, Ryu HG, Na S et al. Procalcitonin-Guided treatment on duration of antibiotic therapy and cost in septic patients (PRODA): a Multi-Center randomized controlled trial. J Korean Med Sci. 2019;34.","DOI":"10.3346\/jkms.2019.34.e110"},{"key":"4352_CR45","first-page":"CD007498","volume":"10","author":"P Schuetz","year":"2017","unstructured":"Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2017;10:CD007498.","journal-title":"Cochrane Database Syst Rev"},{"key":"4352_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11185410","volume":"11","author":"R Igna","year":"2022","unstructured":"Igna R, G\u00eerleanu I, Cojocariu C, Huiban L, Muz\u00eeca C, S\u00eengeap A-M, et al. The role of presepsin and procalcitonin in early diagnosis of bacterial infections in cirrhotic patients with acute-on-chronic liver failure. J Clin Med. 2022;11:5410.","journal-title":"J Clin Med"},{"key":"4352_CR47","doi-asserted-by":"publisher","DOI":"10.1111\/liv.70132","volume":"45","author":"A Finnberg-Kim","year":"2025","unstructured":"Finnberg-Kim A, Pihlsg\u00e5rd M, \u00d6nnerhag K, Melander O, Enh\u00f6rning S. Procalcitonin as a predictive marker of incident liver disease. Liver Int. 2025;45:e70132.","journal-title":"Liver Int"},{"key":"4352_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6130725","volume":"2017","author":"M Sauer","year":"2017","unstructured":"Sauer M, Do\u00df S, Ehler J, Mencke T, Wagner N-M. Procalcitonin impairs liver cell viability and function in vitro: a potential new mechanism of liver dysfunction and failure during sepsis? BioMed Res Int. 2017;2017:6130725.","journal-title":"BioMed Res Int"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04352-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04352-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04352-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:16:31Z","timestamp":1762881391000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04352-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4352"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04352-6","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study conformed to the principles of the Declaration of Helsinki and current ethical regulations; The study was approved by the Institutional Ethics Committee of Kasturba Medical College and Kasturba Hospital Institutional Ethics Committee. (Approval No-IEC-100\/2023) before the study was conducted, and the study was registered with the Clinical Trial Registry - India (CTRI) (Reference number: 069424). Informed consent was obtained from all participants prior to their inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"The authors agreed to have their study published in this journal. Availability of supporting data - The data that support the findings of this study are not openly available due to reasons of sensitivity and are available from the corresponding author upon reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication\u00a0"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"797"}}